ZeroG Aircraft Industry Completes Series A+ Funding Round of Over RMB 100 Million | BlueRun Ventures
Building the Third Transportation Ecosystem on Earth
Building the Third Transportation Ecosystem on Earth
On gain and loss.
Recently, **Xiwei (Suzhou) Biomedical Technology Co., Ltd.** (hereinafter referred to as "Xiwei Biotech") **announced the completion of a nearly RMB 100 million Series A funding round, led by Dalton Venture**. The proceeds will be used to accelerate the development of its pipeline of ophthalmic and regenerative medicine innovations — including artificial biomimetic corneas, implantable contact lenses, artificial corneal endothelium sheets, and artificial dermis — as well as clinical trials, international regulatory registration, and marketing expansion.
A Conversation with Professor Liu Tiangang on Future Industries: Biomanufacturing
Sales Playbooks and Battle-Tested Strategies for Early-Stage Founders
The more human effort you put in, the more intelligence you get out.
Let's Talk Policy Barriers, Demand Discovery, and Channel Building
Between Science and Reality
Interview with the Founder of Glean, an Enterprise AI Search and Knowledge Management Application
The most hardcore, no-fluff technical breakdown of o1.